MedTrace Logo

DEXMEDETOMIDINE in NORMAL VAGINAL DELIVERY

NCT05840328 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-05-03

No results posted yet for this study

Summary

compare the effect of intravenous and epidural dexmetomidine as an adjuvant to local anesthetics in epidural labor analgesia in normal labor

Conditions

  • Painless Vainal Labour

Interventions

DRUG

Dexmedetomidine Injection [Precedex]

interventional drug will be administred either intravenously or epidurally

DRUG

Bupivacaine Injection

intervention drug will be administred epidurally

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Principal Investigators

  • mostafa M mansour, MD · Menoufia University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-05
Primary Completion
2023-06-05
Completion
2023-07-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05840328 on ClinicalTrials.gov